North America Neurovascular Devices Market
No. of Pages: 109 | Report Code: TIPRE00016226 | Category: Life Sciences
No. of Pages: 109 | Report Code: TIPRE00016226 | Category: Life Sciences
Neurovascular devices are used to treat neurovascular diseases that possibly affect the network of blood vessels that surround the brain. Neurovascular disorders lead to incurable conditions such as strokes and aneurysms. Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis, and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.
Strategic insights for the North America Neurovascular Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 1,004.75 Million |
| Market Size by 2027 | US$ 1389.28 Million |
| Global CAGR (2020 - 2027) | 4.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The geographic scope of the North America Neurovascular Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America neurovascular devices market is expected to reach US$ 1389.28 Mn in 2027 from US$ 1,004.75 Mn in 2019. The market is estimated to grow with a CAGR of 4.2% from 2020-2027.
Key factors that are driving growth of the North America Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.
The North America neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period.
The North America neurovascular devices market, based on the application was segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas, and other applications. In 2019, ischemic strokes segment held the largest share of the market and is expected to register the highest CAGR in the market during the forecast period.
Based on end user, the North America neurovascular devices market, was segmented into hospitals, ambulatory surgical centers and specialized clinics. In 2019, hospitals segment held the largest share of the market and is registered to dominate the market at the highest CAGR during the forecast period.
Some of the major primary and secondary sources for North America neurovascular devices market included in the report are Neurological Health Charities Canada (NHCC); World Stroke Organisation (WSO); and World Health Organisation (WHO); among others.
North America North America Neurovascular Devices market –
By Country
Company Profiles
The North America Neurovascular Devices Market is valued at US$ 1,004.75 Million in 2019, it is projected to reach US$ 1389.28 Million by 2027.
As per our report North America Neurovascular Devices Market, the market size is valued at US$ 1,004.75 Million in 2019, projecting it to reach US$ 1389.28 Million by 2027. This translates to a CAGR of approximately 4.2% during the forecast period.
The North America Neurovascular Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Neurovascular Devices Market report:
The North America Neurovascular Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Neurovascular Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Neurovascular Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Neurovascular Devices Market
